George Medicines' recently-approved high blood pressure therapy Widaplik could offer a desperately needed new treatment for ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

Google says it has made a breakthrough in its quantum computing research with an algorithm that can run calculations 13,000 ...

The immediate consequences of the disappointing result are a big reduction in workforce at South San Francisco-based Alector, ...

Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...

Onsite at ESMO 2025, pharmaphorum spoke with Adrian Jubb, head of oncology and neurology clinical development at Corcept, and ...

The company ended the first half of this year with €3.1 billion ($3.6 billion) in cash reserves, and is due to report its ...

Ipsen has reached an agreement to buy fellow French firm ImCheck Therapeutics in a deal that could be worth up to €1 billion ...

Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an ...

The Galleri multi-cancer early detection (MCED) test – which looks for around 50 different types – achieved a seven-fold ...

An oversubscribed seed funding round will give Procyon the financial resources it needs to launch its first diagnostic – ...